These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 2984332)

  • 1. Intravenous methylprednisolone for multiple sclerosis in relapse.
    Barnes MP; Bateman DE; Cleland PG; Dick DJ; Walls TJ; Newman PK; Saunders M; Tilley PJ
    J Neurol Neurosurg Psychiatry; 1985 Feb; 48(2):157-9. PubMed ID: 2984332
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relative efficacy of intravenous methylprednisolone and ACTH in the treatment of acute relapse in MS.
    Thompson AJ; Kennard C; Swash M; Summers B; Yuill GM; Shepherd DI; Roche S; Perkin GD; Loizou LA; Ferner R
    Neurology; 1989 Jul; 39(7):969-71. PubMed ID: 2544829
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of corticosteroids in multiple sclerosis by consultant neurologists in the United Kingdom.
    Tremlett HL; Luscombe DK; Wiles CM
    J Neurol Neurosurg Psychiatry; 1998 Sep; 65(3):362-5. PubMed ID: 9728950
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Corticosteroids and multiple sclerosis.
    Miller DH
    J Neurol Neurosurg Psychiatry; 1998 Sep; 65(3):290. PubMed ID: 9728938
    [No Abstract]   [Full Text] [Related]  

  • 5. "Bolus" methylprednisolone versus ACTH in the treatment of multiple sclerosis.
    Abbruzzese G; Gandolfo C; Loeb C
    Ital J Neurol Sci; 1983 Jun; 4(2):169-72. PubMed ID: 6311774
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Steroid therapy for multiple sclerosis].
    Oishi C; Sakuta M
    Nihon Rinsho; 2003 Aug; 61(8):1361-6. PubMed ID: 12962024
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Double-blind randomized trial of ACTH versus dexamethasone versus methylprednisolone in multiple sclerosis bouts. Clinical, cerebrospinal fluid and neurophysiological results.
    Milanese C; La Mantia L; Salmaggi A; Campi A; Eoli M; Scaioli V; Nespolo A; Corridori F
    Eur Neurol; 1989; 29(1):10-4. PubMed ID: 2540005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A double-blind controlled trial of high dose methylprednisolone in patients with multiple sclerosis: 1. Clinical effects.
    Milligan NM; Newcombe R; Compston DA
    J Neurol Neurosurg Psychiatry; 1987 May; 50(5):511-6. PubMed ID: 3295122
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Critic study of multiple sclerosis treatment by chlorambucil and intraspinal corticotherapy. Apropos of 100 cases followed up from 2 to 9 years].
    Sigwald J; Mazalton A; Raymondeaud C; Piot C; Jacquillat C
    Rev Neurol (Paris); 1973 Jan; 128(1):72-7. PubMed ID: 4367744
    [No Abstract]   [Full Text] [Related]  

  • 10. Oral versus intravenous methylprednisolone for the treatment of multiple sclerosis relapses: A meta-analysis of randomized controlled trials.
    Liu S; Liu X; Chen S; Xiao Y; Zhuang W
    PLoS One; 2017; 12(11):e0188644. PubMed ID: 29176905
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute improvement in exacerbating multiple sclerosis produced by intravenous administration of mannitol.
    Stefoski D; Davis FA; Schauf CL
    Ann Neurol; 1985 Oct; 18(4):443-50. PubMed ID: 3000278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methylprednisolone in multiple sclerosis: a comparative dose study.
    Bindoff L; Lyons PR; Newman PK; Saunders M
    J Neurol Neurosurg Psychiatry; 1988 Aug; 51(8):1108-9. PubMed ID: 3063777
    [No Abstract]   [Full Text] [Related]  

  • 13. Possible beneficial effect of high-dose intravenous steroid therapy in acute demyelinating disease and transverse myelitis.
    Dowling PC; Bosch VV; Cook SD
    Neurology; 1980 Jul; 30(7 Pt 2):33-6. PubMed ID: 6248819
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Steroid therapy in multiple sclerosis].
    Beer S; Kesselring J
    Schweiz Med Wochenschr; 1991 Jun; 121(26):961-9. PubMed ID: 1650496
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Therapeutic indications for acute episodes of multiple sclerosis].
    Brochet B
    Rev Neurol (Paris); 2001 Sep; 157(8-9 Pt 2):988-95. PubMed ID: 11787365
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment of multiple sclerosis with Lyoproper].
    Aschoff JC; Conrad B
    Med Klin; 1971 Jun; 66(30):1055-8. PubMed ID: 4328079
    [No Abstract]   [Full Text] [Related]  

  • 17. High-dose intravenous methylprednisolone in the treatment of multiple sclerosis: clinical-immunologic correlations.
    Durelli L; Cocito D; Riccio A; Barile C; Bergamasco B; Baggio GF; Perla F; Delsedime M; Gusmaroli G; Bergamini L
    Neurology; 1986 Feb; 36(2):238-43. PubMed ID: 3511404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Early results of the treatment of chronic progressive forms of multiple sclerosis with cyclophosphamide and ACTH].
    Wender M; Tokarz-Kupczyk E; Mularek O
    Neurol Neurochir Pol; 1988; 22(5):399-403. PubMed ID: 2854886
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomised trial of oral and intravenous methylprednisolone in acute relapses of multiple sclerosis.
    Barnes D; Hughes RA; Morris RW; Wade-Jones O; Brown P; Britton T; Francis DA; Perkin GD; Rudge P; Swash M; Katifi H; Farmer S; Frankel J
    Lancet; 1997 Mar; 349(9056):902-6. PubMed ID: 9093250
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Five-day regimen of intramuscular or subcutaneous self-administered adrenocorticotropic hormone gel for acute exacerbations of multiple sclerosis: a prospective, randomized, open-label pilot trial.
    Simsarian JP; Saunders C; Smith DM
    Drug Des Devel Ther; 2011; 5():381-9. PubMed ID: 21792296
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.